Ju Fu Tang Biotech (08217) Publishes Monthly Return for February 2026
Bulletin Express
Mar 03
Ju Fu Tang Biotech Holdings Co., Ltd. (stock code: 08217) reported that its authorized share capital remained at 500.00 million ordinary shares with a par value of HKD0.16 each, totaling HKD80.00 million as of February 28, 2026. There was no change from the previous month.
The total number of issued shares remained at 301.86 million with no increase or decrease reported. Public float requirements were confirmed to be in compliance at the minimum threshold of 25%. Two share option schemes remained unchanged: one with 10.70 million outstanding options, and another with 9.14 million outstanding options. No new shares were issued during the period under review.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.